When Do Persistent Bowel Changes Need Prompt Assessment for Possible Colon Cancer?

How can I tell the difference between IBS symptoms and colon cancer symptoms?

You cannot reliably tell from symptoms alone; the useful move is to spot the overlap, record what has changed, and get a clinician to assess the pattern. The National Cancer Institute lists diarrhoea, constipation, a feeling that the bowel does not empty, narrower or changed-shape stools, abdominal discomfort, fatigue, unexplained weight loss, vomiting, and blood in stool among possible colon-cancer symptoms. It also makes the central point: these symptoms can come from other conditions.

That is why “it feels like IBS” is not a finish line. It is a description of a symptom pattern, not confirmation of a cause. The practical distinction is not one magic symptom; it is whether the issue is persistent, unexplained, changing, or arriving with warning signs such as bleeding, anaemia, weight loss, or fatigue.

For younger adults, this matters because routine average-risk screening generally starts after many early-onset cases occur. In the National Cancer Institute's 2023 report on a study of people aged 18 to 49 years, one warning sign in the 3 months to 2 years before diagnosis was linked with about twice the likelihood of early-onset colorectal cancer, while three or more signs were linked with six times the likelihood. Rectal bleeding had the strongest association.

Use a simple pattern brief before an appointment. Write down when the change began, what changed, whether blood appeared, whether pain is present, whether symptoms are getting worse, and any family history the clinician may need. Lead with the highest-stakes fact: “My bowel habit has changed and I have also noticed rectal bleeding.” That reduces cognitive load and prevents the key detail being buried under a long symptom history.

The 2024 JAMA Network Open systematic review gives the overlap real weight: across 81 studies involving 24,908,126 patients younger than 50 years, hematochezia occurred in 45% of people with early-onset colorectal cancer, abdominal pain in 40%, and altered bowel habits in 27%. Those figures do not diagnose cancer. They explain why a persistent cluster deserves assessment.

Can hemorrhoids cause blood in stool, or could it be colon cancer?

Haemorrhoids can cause blood in stool, but bleeding cannot safely be assigned to haemorrhoids without assessment when it persists or comes with other warning signs. The National Institute of Diabetes and Digestive and Kidney Diseases says internal haemorrhoids can cause bright-red bleeding on stool, toilet paper, or in the toilet bowl after a bowel movement.

That description is useful but incomplete. The same NIDDK guidance states that not every anal symptom is caused by a haemorrhoid and that rectal bleeding can also be a sign of Crohn's disease, ulcerative colitis, colon cancer, or rectal cancer. Bright-red blood is therefore not a shortcut to reassurance.

Replace the weak message, “It is probably piles,” with a complete one: “There is bright-red bleeding, it has continued, and there are also changes in bowel habit or pain.” The first version closes the investigation before it starts. The second gives the clinician the facts needed to choose the next step.

The NIDDK advises seeking medical help for rectal bleeding and for haemorrhoid symptoms that continue after 1 week of at-home treatment. The NHS adds an urgent escalation line: black or dark-red stool and bloody diarrhoea warrant urgent medical help. Nonstop rectal bleeding, a large amount of blood, or large clots warrant emergency care, according to the NHS bowel-cancer symptom guidance.

Constipation can have many explanations, and practical food choices are a separate question from investigating bleeding or other red flags. For a food-focused discussion, see Should I Choose Kiwi, Prunes, or Psyllium for Constipation?. It is not a substitute for assessment of persistent symptoms.

Should a 20- or 30-year-old worry about colon cancer symptoms?

Age should not be used to dismiss persistent colorectal-cancer warning signs in a person in their 20s or 30s. The National Cancer Institute's 2023 report states that half of early-onset colorectal cancers are diagnosed before age 45, which is below the age at which routine average-risk screening generally begins.

This is not a reason to assume cancer from a stomach ache or a brief bowel change. It is a reason to avoid the opposite error: assuming that youth settles the question. The 2024 JAMA Network Open review reported an average time from symptoms to diagnosis of 6.4 months and a median of 4 months, showing that delays of 4 to 6 months were common in the studies reviewed.

Clinicians may consider personal and family history, an abdominal examination, a digital rectal examination, blood tests, stool blood testing, sigmoidoscopy, colonoscopy, imaging, or biopsy, according to the National Cancer Institute's colon-cancer information. The right pathway depends on the symptom pattern and clinical assessment. The point is to bring the whole pattern into the room.

FIT is one part of that pathway, not a veto. The 2022 guideline from the Association of Coloproctology of Great Britain and Ireland and the British Society of Gastroenterology uses faecal haemoglobin of 10 micrograms per gram or more as a threshold for urgent primary-care referral. But the same 2022 guideline states that people should not be excluded from referral on the basis of FIT testing alone; persistent, unexplained symptoms with ongoing clinical concern can still require secondary-care evaluation below that threshold.

The bottom line is direct: do not make age, an IBS label, or a haemorrhoid explanation carry more certainty than it can. Bring a short symptom timeline, state the red flags first, and ask what assessment is appropriate for the full pattern.